Cough
Whooping Cough
Antitussive Agents
Citric Acid
Codeine
Reflex
Respiratory Sounds
Expectorants
Bronchitis
Bordetella pertussis
Asthma
Chronic Disease
Nasal Decongestants
Common Cold
Respiratory Tract Diseases
Guaifenesin
Sputum
Bronchial Provocation Tests
Respiratory Tract Infections
Respiration Disorders
Analysis with a combination of macrorestriction endonucleases reveals a high degree of polymorphism among Bordetella pertussis isolates in eastern France. (1/815)
From 1990 to 1996, routine screening for whooping cough identified 399 patients with a calmodulin-dependent adenylate cyclase-positive test result and yielded 69 Bordetella pertussis isolates. None of the patients were fully vaccinated, and most were less than 6 months old. Analysis of total DNA by pulsed-field gel electrophoresis (PFGE) after XbaI, SpeI, or DraI macrorestriction yielded 19, 15, and 5 different patterns, respectively, whereas ribotyping failed to demonstrate any strain polymorphism. Discrimination among the isolates was improved by combining the PFGE profiles. Some patterns were more frequent, but the corresponding patients were not clearly epidemiologically related. The patterns for two strains obtained during a 3-month period from patients who were neighbors differed by the length of a single DNA fragment. These data strongly suggest that one type of isolate is widely spread throughout the world and is carried by individuals other than patients who develop a true illness. (+info)Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. (2/815)
Levels of IgG antibody to pertussis toxin (PT) and filamentous hemagglutinin (FHA) were measured in paired serum samples from 781 patients fulfilling at least one laboratory criterion for pertussis that was suggested by an ad hoc committee sponsored by the World Health Organization. The patients were participants or family members of participants in a double-blind efficacy trial of a monocomponent pertussis toxoid vaccine. Of 596 nonvaccinated children, 90% had significant (two-fold or more) rises in PT IgG and FHA IgG levels. Only 17 (32%) of 53 children previously vaccinated with three doses of pertussis toxoid had rises in PT IgG levels because they already had elevated PT IgG levels in their acute-phase serum samples. PT IgG and FHA IgG levels were significantly higher in acute-phase serum samples from 29 adults than in acute-phase serum samples from the nonvaccinated children. Nevertheless, significant rises in levels of PT IgG (79% of samples) and FHA IgG (90%) were demonstrated in adults. In conclusion, assay of PT IgG and FHA IgG in paired serum samples is highly sensitive for diagnosing pertussis in nonvaccinated individuals. Assay of PT IgG levels in paired sera is significantly less sensitive for diagnosis of pertussis for children vaccinated with pertussis toxoid. (+info)Evidence of efficacy of the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis vaccine but not the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis vaccine against Bordetella parapertussis infection. (3/815)
A subanalysis of a recent cohort efficacy trial of a pertussis vaccine was performed to determine its efficacy against cough illnesses due to Bordetella parapertussis infections. Infants received four doses of either the Lederle/Takeda acellular pertussis component diphtheria and tetanus toxoids and pertussis (DTaP) vaccine or the Lederle whole-cell component diphtheria and tetanus toxoids and pertussis (DTP) vaccine at 3, 4.5, 6, and 15-18 months of age; controls received three doses of diphtheria and tetanus toxoids (DT) vaccine only. All subjects were prospectively followed for cough illnesses of > or = 7 days' duration; cases of B. parapertussis infection were confirmed by positive culture, household contact, or serology. Seventy-six cough illnesses due to B. parapertussis were identified; 24 occurred in 929 DTaP recipients, 37 in 937 DTP recipients, and 15 in 321 DT recipients, resulting in an efficacy of 50% for DTaP vaccine (95% CI [confidence interval], 5% to 74%) and 21% for DTP vaccine (95% CI, -45% to 56%). The data in the present analysis suggest that the Lederle/Takeda DTaP vaccine but not the Lederle whole-cell component DTP vaccine has efficacy against B. parapertussis infection. (+info)Capture-recapture method for estimating misclassification errors: application to the measurement of vaccine efficacy in randomized controlled trials. (4/815)
BACKGROUND: The measure of efficacy is optimally performed by randomized controlled trials. However, low specificity of the judgement criteria is known to bias toward lower estimation, while low sensitivity increases the required sample size. A common technique for ensuring good specificity without a drop in sensitivity is to use several diagnostic tests in parallel, with each of them being specific. This approach is similar to the more general situation of case-counting from multiple data sources, and this paper explores the application of the capture-recapture method for the analysis of the estimates of efficacy. METHOD: An illustration of this application is derived from a study on the efficacy of pertussis vaccines where the outcome was based on > or =21 days of cough confirmed by at least one of three criteria performed independently for each subject: bacteriology, serology, or epidemiological link. Log-linear methods were applied to these data considered as three sources of information. RESULTS: The best model considered the three simple effects and an interaction term between bacteriology and epidemiological linkage. Among the 801 children experiencing > or =21 days of cough, it was estimated that 93 cases were missed, leading to a corrected total of 413 confirmed cases. The relative vaccine efficacy estimated from the same model was 1.50 (95% confidence interval: 1.24-1.82), similar to the crude estimate of 1.59 and confirming better protection afforded by one of the two vaccines. CONCLUSION: This method allows supporting analysis to interpret primary estimates of vaccine efficacy. (+info)Pertussis is increasing in unimmunized infants: is a change in policy needed? (5/815)
The proportion and trend in absolute number of pertussis notifications in young infants has increased each year in England and Wales since the accelerated immunization schedule was introduced. We report five infants all less than 3 months of age admitted with life threatening pertussis infection to two paediatric intensive care units. Despite aggressive cardiorespiratory support measures, three of the infants died. Pertussis remains a significant cause of morbidity and mortality in unimmunized infants. In this age group presentation is likely to be atypical and infection more severe. Public health measures to prevent the disease could be strengthened. Chemoprophylaxis should be offered to susceptible contacts and booster vaccinations against pertussis considered. (+info)Respiratory diseases among U.S. military personnel: countering emerging threats. (6/815)
Emerging respiratory disease agents, increased antibiotic resistance, and the loss of effective vaccines threaten to increase the incidence of respiratory disease in military personnel. We examine six respiratory pathogens (adenoviruses, influenza viruses, Streptococcus pneumoniae, Streptococcus pyogenes, Mycoplasma pneumoniae, and Bordetella pertussis) and review the impact of the diseases they cause, past efforts to control these diseases in U.S. military personnel, as well as current treatment and surveillance strategies, limitations in diagnostic testing, and vaccine needs. (+info)Bordetella holmesii-like organisms isolated from Massachusetts patients with pertussis-like symptoms. (7/815)
We isolated Bordetella holmesii, generally associated with septicemia in patients with underlying conditions, from nasopharyngeal specimens of otherwise healthy young persons with a cough. The proportion of B. holmesii-positive specimens submitted to the Massachusetts State Laboratory Institute increased from 1995 to 1998. (+info)Stochastic dynamics and a power law for measles variability. (8/815)
Since the discovery of a power law scaling between the mean and variance of natural populations, this phenomenon has been observed for a variety of species. Here, we show that the same form of power law scaling also occurs in measles case reports in England and Wales. Remarkably this power law holds over four orders of magnitude. We consider how the natural experiment of vaccination affects the slope of the power law. By examining simple generic models, we are able to predict the effects of stochasticity and coupling and we propose a new phenomenon associated with the critical community size. (+info)A cough is a reflex action that helps to clear the airways of irritants, foreign particles, or excess mucus or phlegm. It is characterized by a sudden, forceful expulsion of air from the lungs through the mouth and nose. A cough can be acute (short-term) or chronic (long-term), and it can be accompanied by other symptoms such as chest pain, shortness of breath, or fever. Coughing can be caused by various factors, including respiratory infections, allergies, asthma, environmental pollutants, gastroesophageal reflux disease (GERD), and chronic lung diseases such as chronic obstructive pulmonary disease (COPD) and bronchitis. In some cases, a cough may be a symptom of a more serious underlying condition, such as heart failure or lung cancer.
Whoopering Cough, also known as Pertussis, is a highly contagious respiratory infection caused by the bacterium Bordetella pertussis. It is characterized by severe coughing fits followed by a high-pitched "whoop" sound during inspiration. The disease can affect people of all ages, but it is most dangerous for babies and young children. Symptoms typically develop within 5 to 10 days after exposure and include runny nose, low-grade fever, and a mild cough. After a week or two, the cough becomes more severe and is often followed by vomiting and exhaustion. Complications can be serious, especially in infants, and may include pneumonia, seizures, brain damage, or death. Treatment usually involves antibiotics to kill the bacteria and reduce the severity of symptoms. Vaccination is available and recommended for the prevention of whooping cough.
Antitussive agents are medications that are used to suppress cough. They work by numbing the throat and interrupting the cough reflex. Some common antitussives include dextromethorphan, codeine, and hydrocodone. These medications can be found in various over-the-counter and prescription cough and cold products. It is important to use antitussives only as directed, as they can have side effects such as drowsiness, constipation, and slowed breathing. Additionally, it's important to note that long term use of opioid antitussive like codeine and hydrocodone are not recommended due to the risk of addiction and other serious side effects.
Capsaicin is defined in medical terms as the active component of chili peppers (genus Capsicum) that produces a burning sensation when it comes into contact with mucous membranes or skin. It is a potent irritant and is used topically as a counterirritant in some creams and patches to relieve pain. Capsaicin works by depleting substance P, a neurotransmitter that relays pain signals to the brain, from nerve endings.
Here is the medical definition of capsaicin from the Merriam-Webster's Medical Dictionary:
caпсаісіn : an alkaloid (C18H27NO3) that is the active principle of red peppers and is used in topical preparations as a counterirritant and analgesic.
Citric acid is a weak organic acid that is widely found in nature, particularly in citrus fruits such as lemons and oranges. Its chemical formula is C6H8O7, and it exists in a form known as a tribasic acid, which means it can donate three protons in chemical reactions.
In the context of medical definitions, citric acid may be mentioned in relation to various physiological processes, such as its role in the Krebs cycle (also known as the citric acid cycle), which is a key metabolic pathway involved in energy production within cells. Additionally, citric acid may be used in certain medical treatments or therapies, such as in the form of citrate salts to help prevent the formation of kidney stones. It may also be used as a flavoring agent or preservative in various pharmaceutical preparations.
Codeine is a opiate analgesic, commonly used for its pain-relieving and cough suppressant properties. It is typically prescribed for mild to moderately severe pain, and is also found in some over-the-counter cold and cough medications. Codeine works by binding to opioid receptors in the brain and spinal cord, which helps to reduce the perception of pain. Like other opiates, codeine can produce side effects such as drowsiness, constipation, and respiratory depression, and it carries a risk of dependence and addiction with long-term use. It is important to follow your healthcare provider's instructions carefully when taking codeine, and to inform them of any other medications you are taking, as well as any medical conditions you may have.
A reflex is an automatic, involuntary and rapid response to a stimulus that occurs without conscious intention. In the context of physiology and neurology, it's a basic mechanism that involves the transmission of nerve impulses between neurons, resulting in a muscle contraction or glandular secretion.
Reflexes are important for maintaining homeostasis, protecting the body from harm, and coordinating movements. They can be tested clinically to assess the integrity of the nervous system, such as the knee-j jerk reflex, which tests the function of the L3-L4 spinal nerve roots and the sensitivity of the stretch reflex arc.
Respiratory sounds are the noises produced by the airflow through the respiratory tract during breathing. These sounds can provide valuable information about the health and function of the lungs and airways. They are typically categorized into two main types: normal breath sounds and adventitious (or abnormal) breath sounds.
Normal breath sounds include:
1. Vesicular breath sounds: These are soft, low-pitched sounds heard over most of the lung fields during quiet breathing. They are produced by the movement of air through the alveoli and smaller bronchioles.
2. Bronchovesicular breath sounds: These are medium-pitched, hollow sounds heard over the mainstem bronchi and near the upper sternal border during both inspiration and expiration. They are a combination of vesicular and bronchial breath sounds.
Abnormal or adventitious breath sounds include:
1. Crackles (or rales): These are discontinuous, non-musical sounds that resemble the crackling of paper or bubbling in a fluid-filled container. They can be heard during inspiration and are caused by the sudden opening of collapsed airways or the movement of fluid within the airways.
2. Wheezes: These are continuous, musical sounds resembling a whistle. They are produced by the narrowing or obstruction of the airways, causing turbulent airflow.
3. Rhonchi: These are low-pitched, rumbling, continuous sounds that can be heard during both inspiration and expiration. They are caused by the vibration of secretions or fluids in the larger airways.
4. Stridor: This is a high-pitched, inspiratory sound that resembles a harsh crowing or barking noise. It is usually indicative of upper airway narrowing or obstruction.
The character, location, and duration of respiratory sounds can help healthcare professionals diagnose various respiratory conditions, such as pneumonia, chronic obstructive pulmonary disease (COPD), asthma, and bronchitis.
Expectorants are a type of medication that help to thin and loosen mucus in the airways, making it easier to cough up and clear the airways. They work by increasing the production of fluid in the respiratory tract, which helps to moisten and soften thick or sticky mucus. This makes it easier for the cilia (tiny hair-like structures that line the airways) to move the mucus out of the lungs and into the throat, where it can be swallowed or spit out.
Expectorants are often used to treat respiratory conditions such as bronchitis, pneumonia, and chronic obstructive pulmonary disease (COPD), which can cause excessive mucus production and difficulty breathing. Some common expectorants include guaifenesin, iodinated glycerol, and potassium iodide.
It is important to follow the dosage instructions carefully when taking expectorants, as taking too much can lead to side effects such as nausea, vomiting, and diarrhea. It is also important to drink plenty of fluids while taking expectorants, as this can help to thin the mucus and make it easier to cough up.
Bronchitis is a medical condition characterized by inflammation of the bronchi, which are the large airways that lead to the lungs. This inflammation can cause a variety of symptoms, including coughing, wheezing, chest tightness, and shortness of breath. Bronchitis can be either acute or chronic.
Acute bronchitis is usually caused by a viral infection, such as a cold or the flu, and typically lasts for a few days to a week. Symptoms may include a productive cough (coughing up mucus or phlegm), chest discomfort, and fatigue. Acute bronchitis often resolves on its own without specific medical treatment, although rest, hydration, and over-the-counter medications to manage symptoms may be helpful.
Chronic bronchitis, on the other hand, is a long-term condition that is characterized by a persistent cough with mucus production that lasts for at least three months out of the year for two consecutive years. Chronic bronchitis is typically caused by exposure to irritants such as cigarette smoke, air pollution, or occupational dusts and chemicals. It is often associated with chronic obstructive pulmonary disease (COPD), which includes both chronic bronchitis and emphysema.
Treatment for chronic bronchitis may include medications to help open the airways, such as bronchodilators and corticosteroids, as well as lifestyle changes such as smoking cessation and avoiding irritants. In severe cases, oxygen therapy or lung transplantation may be necessary.
'Bordetella pertussis' is a gram-negative, coccobacillus bacterium that is the primary cause of whooping cough (pertussis) in humans. This highly infectious disease affects the respiratory system, resulting in severe coughing fits and other symptoms. The bacteria's ability to evade the immune system and attach to ciliated epithelial cells in the respiratory tract contributes to its pathogenicity.
The bacterium produces several virulence factors, including pertussis toxin, filamentous hemagglutinin, fimbriae, and tracheal cytotoxin, which contribute to the colonization and damage of respiratory tissues. The pertussis toxin, in particular, is responsible for many of the clinical manifestations of the disease, such as the characteristic whooping cough and inhibition of immune responses.
Prevention and control measures primarily rely on vaccination using acellular pertussis vaccines (aP) or whole-cell pertussis vaccines (wP), which are included in combination with other antigens in pediatric vaccines. Continuous efforts to improve vaccine efficacy, safety, and coverage are essential for controlling the global burden of whooping cough caused by Bordetella pertussis.
Asthma is a chronic respiratory disease characterized by inflammation and narrowing of the airways, leading to symptoms such as wheezing, coughing, shortness of breath, and chest tightness. The airway obstruction in asthma is usually reversible, either spontaneously or with treatment.
The underlying cause of asthma involves a combination of genetic and environmental factors that result in hypersensitivity of the airways to certain triggers, such as allergens, irritants, viruses, exercise, and emotional stress. When these triggers are encountered, the airways constrict due to smooth muscle spasm, swell due to inflammation, and produce excess mucus, leading to the characteristic symptoms of asthma.
Asthma is typically managed with a combination of medications that include bronchodilators to relax the airway muscles, corticosteroids to reduce inflammation, and leukotriene modifiers or mast cell stabilizers to prevent allergic reactions. Avoiding triggers and monitoring symptoms are also important components of asthma management.
There are several types of asthma, including allergic asthma, non-allergic asthma, exercise-induced asthma, occupational asthma, and nocturnal asthma, each with its own set of triggers and treatment approaches. Proper diagnosis and management of asthma can help prevent exacerbations, improve quality of life, and reduce the risk of long-term complications.
A chronic disease is a long-term medical condition that often progresses slowly over a period of years and requires ongoing management and care. These diseases are typically not fully curable, but symptoms can be managed to improve quality of life. Common chronic diseases include heart disease, stroke, cancer, diabetes, arthritis, and COPD (chronic obstructive pulmonary disease). They are often associated with advanced age, although they can also affect children and younger adults. Chronic diseases can have significant impacts on individuals' physical, emotional, and social well-being, as well as on healthcare systems and society at large.
Nasal decongestants are medications that are used to relieve nasal congestion, or a "stuffy nose," by narrowing the blood vessels in the lining of the nose, which helps to reduce swelling and inflammation. This can help to make breathing easier and can also help to alleviate other symptoms associated with nasal congestion, such as sinus pressure and headache.
There are several different types of nasal decongestants available, including over-the-counter (OTC) and prescription options. Some common OTC nasal decongestants include pseudoephedrine (Sudafed) and phenylephrine (Neo-Synephrine), which are available in the form of tablets, capsules, liquids, and nasal sprays. Prescription nasal decongestants may be stronger than OTC options and may be prescribed for longer periods of time.
It is important to follow the instructions on the label when using nasal decongestants, as they can have side effects if not used properly. Some potential side effects of nasal decongestants include increased heart rate, blood pressure, and anxiety. It is also important to note that nasal decongestants should not be used for longer than a few days at a time, as prolonged use can actually make nasal congestion worse (this is known as "rebound congestion"). If you have any questions about using nasal decongestants or if your symptoms persist, it is best to speak with a healthcare provider.
The common cold is a viral infectious disease of the upper respiratory tract. It primarily affects the nose, throat, sinuses, and upper airways. The main symptoms include sore throat, runny or stuffy nose, sneezing, cough, and fatigue. The common cold is often caused by rhinoviruses and can also be caused by other viruses like coronaviruses, coxsackieviruses, and adenoviruses. It is usually spread through respiratory droplets when an infected person coughs, sneezes, or talks. The common cold is self-limiting and typically resolves within 7-10 days, although some symptoms may last up to three weeks. There is no specific treatment for the common cold, and management focuses on relieving symptoms with over-the-counter medications, rest, and hydration. Preventive measures include frequent hand washing, avoiding close contact with sick individuals, and not touching the face with unwashed hands.
Respiratory tract diseases refer to a broad range of medical conditions that affect the respiratory system, which includes the nose, throat (pharynx), windpipe (trachea), bronchi, bronchioles, and lungs. These diseases can be categorized into upper and lower respiratory tract infections based on the location of the infection.
Upper respiratory tract infections affect the nose, sinuses, pharynx, and larynx, and include conditions such as the common cold, flu, sinusitis, and laryngitis. Symptoms often include nasal congestion, sore throat, cough, and fever.
Lower respiratory tract infections affect the trachea, bronchi, bronchioles, and lungs, and can be more severe. They include conditions such as pneumonia, bronchitis, and tuberculosis. Symptoms may include cough, chest congestion, shortness of breath, and fever.
Respiratory tract diseases can also be caused by allergies, irritants, or genetic factors. Treatment varies depending on the specific condition and severity but may include medications, breathing treatments, or surgery in severe cases.
Guaifenesin is a medication that belongs to the class of expectorants. According to the Medical Dictionary by Farlex, guaifenesin is defined as:
"A salicylate-free agent with expectorant properties; it increases respiratory secretions and decreases their viscosity, making coughs more productive. It is used as an antitussive in bronchitis and other respiratory tract infections."
Guaifenesin works by helping to thin and loosen mucus in the airways, making it easier to cough up and clear the airways of bothersome mucus and phlegm. It is commonly available as an over-the-counter medication for relieving symptoms associated with a common cold, flu, or other respiratory infections.
Guaifenesin can be found in various forms, such as tablets, capsules, liquid, or extended-release products. Common brand names of guaifenesin include Mucinex and Robitussin. It is important to follow the recommended dosage on the product label and consult a healthcare professional if you have any questions about its use or if your symptoms persist for more than one week.
Sputum is defined as a mixture of saliva and phlegm that is expelled from the respiratory tract during coughing, sneezing or deep breathing. It can be clear, mucoid, or purulent (containing pus) depending on the underlying cause of the respiratory issue. Examination of sputum can help diagnose various respiratory conditions such as infections, inflammation, or other lung diseases.
Bronchial provocation tests are a group of medical tests used to assess the airway responsiveness of the lungs by challenging them with increasing doses of a specific stimulus, such as methacholine or histamine, which can cause bronchoconstriction (narrowing of the airways) in susceptible individuals. These tests are often performed to diagnose and monitor asthma and other respiratory conditions that may be associated with heightened airway responsiveness.
The most common type of bronchial provocation test is the methacholine challenge test, which involves inhaling increasing concentrations of methacholine aerosol via a nebulizer. The dose response is measured by monitoring lung function (usually through spirometry) before and after each exposure. A positive test is indicated when there is a significant decrease in forced expiratory volume in one second (FEV1) or other measures of airflow, which suggests bronchial hyperresponsiveness.
Other types of bronchial provocation tests include histamine challenges, exercise challenges, and mannitol challenges. These tests have specific indications, contraindications, and protocols that should be followed to ensure accurate results and patient safety. Bronchial provocation tests are typically conducted in a controlled clinical setting under the supervision of trained healthcare professionals.
Respiratory tract infections (RTIs) are infections that affect the respiratory system, which includes the nose, throat (pharynx), voice box (larynx), windpipe (trachea), bronchi, and lungs. These infections can be caused by viruses, bacteria, or, less commonly, fungi.
RTIs are classified into two categories based on their location: upper respiratory tract infections (URTIs) and lower respiratory tract infections (LRTIs). URTIs include infections of the nose, sinuses, throat, and larynx, such as the common cold, flu, laryngitis, and sinusitis. LRTIs involve the lower airways, including the bronchi and lungs, and can be more severe. Examples of LRTIs are pneumonia, bronchitis, and bronchiolitis.
Symptoms of RTIs depend on the location and cause of the infection but may include cough, congestion, runny nose, sore throat, difficulty breathing, wheezing, fever, fatigue, and chest pain. Treatment for RTIs varies depending on the severity and underlying cause of the infection. For viral infections, treatment typically involves supportive care to manage symptoms, while antibiotics may be prescribed for bacterial infections.
Respiratory disorders are a group of conditions that affect the respiratory system, including the nose, throat (pharynx), windpipe (trachea), bronchi, lungs, and diaphragm. These disorders can make it difficult for a person to breathe normally and may cause symptoms such as coughing, wheezing, shortness of breath, and chest pain.
There are many different types of respiratory disorders, including:
1. Asthma: A chronic inflammatory disease that causes the airways to become narrow and swollen, leading to difficulty breathing.
2. Chronic obstructive pulmonary disease (COPD): A group of lung diseases, including emphysema and chronic bronchitis, that make it hard to breathe.
3. Pneumonia: An infection of the lungs that can cause coughing, chest pain, and difficulty breathing.
4. Lung cancer: A type of cancer that forms in the tissues of the lungs and can cause symptoms such as coughing, chest pain, and shortness of breath.
5. Tuberculosis (TB): A bacterial infection that mainly affects the lungs but can also affect other parts of the body.
6. Sleep apnea: A disorder that causes a person to stop breathing for short periods during sleep.
7. Interstitial lung disease: A group of disorders that cause scarring of the lung tissue, leading to difficulty breathing.
8. Pulmonary fibrosis: A type of interstitial lung disease that causes scarring of the lung tissue and makes it hard to breathe.
9. Pleural effusion: An abnormal accumulation of fluid in the space between the lungs and chest wall.
10. Lung transplantation: A surgical procedure to replace a diseased or failing lung with a healthy one from a donor.
Respiratory disorders can be caused by a variety of factors, including genetics, exposure to environmental pollutants, smoking, and infections. Treatment for respiratory disorders may include medications, oxygen therapy, breathing exercises, and lifestyle changes. In some cases, surgery may be necessary to treat the disorder.
"Inhalation administration" is a medical term that refers to the method of delivering medications or therapeutic agents directly into the lungs by inhaling them through the airways. This route of administration is commonly used for treating respiratory conditions such as asthma, COPD (chronic obstructive pulmonary disease), and cystic fibrosis.
Inhalation administration can be achieved using various devices, including metered-dose inhalers (MDIs), dry powder inhalers (DPIs), nebulizers, and soft-mist inhalers. Each device has its unique mechanism of delivering the medication into the lungs, but they all aim to provide a high concentration of the drug directly to the site of action while minimizing systemic exposure and side effects.
The advantages of inhalation administration include rapid onset of action, increased local drug concentration, reduced systemic side effects, and improved patient compliance due to the ease of use and non-invasive nature of the delivery method. However, proper technique and device usage are crucial for effective therapy, as incorrect usage may result in suboptimal drug deposition and therapeutic outcomes.